Get the Stockscreener App
2.03
1.46%
-0.03
Cerus Corp stock is traded at $2.03, with a volume of 553.26K.
It is down -1.46% in the last 24 hours and up +15.34% over the past month.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
See More
Previous Close:
$2.06
Open:
$2.06
24h Volume:
553.26K
Relative Volume:
0.40
Market Cap:
$389.94M
Revenue:
$156.37M
Net Income/Loss:
$-37.49M
P/E Ratio:
-9.6667
EPS:
-0.21
Net Cash Flow:
$-47.77M
1W Performance:
-2.87%
1M Performance:
+15.34%
6M Performance:
+49.26%
1Y Performance:
+22.29%
1-Day Range:
$2.00
$2.06
1-Week Range:
$2.00
$2.21
52-Week Range:
$1.12
$2.26
Cerus Corp Stock (CERS) Company Profile
Name
Cerus Corp
Sector
Industry
Phone
(925) 288-6000
Address
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
2.03 | 395.70M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
124.84 | 217.03B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.06 | 142.51B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.22 | 135.66B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.52 | 124.70B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.85 | 50.07B | 5.88B | 1.34B | 799.60M | 2.3489 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-24 | Initiated | Craig Hallum | Buy |
| Jan-20-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-17-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-08-20 | Resumed | BTIG Research | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| Feb-26-20 | Initiated | BTIG Research | Buy |
| Nov-13-19 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-28-19 | Initiated | Stifel | Buy |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-08-17 | Resumed | BTIG Research | Neutral |
| Jul-07-16 | Resumed | Cantor Fitzgerald | Buy |
| Dec-17-15 | Downgrade | Wedbush | Outperform → Neutral |
| May-02-14 | Reiterated | MLV & Co | Buy |
| Apr-24-13 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-15-13 | Reiterated | MLV & Co | Buy |
| Apr-17-12 | Initiated | Cantor Fitzgerald | Buy |
| Feb-29-12 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-10-11 | Reiterated | MLV & Co | Buy |
| Jun-03-11 | Initiated | Wedbush | Outperform |
| Mar-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-09-10 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-26-09 | Upgrade | Avondale | Mkt Perform → Mkt Outperform |
View All
Cerus Corp Stock (CERS) Latest News
TD Cowen Sees Compelling Long-Term Value in Cerus Corporation (CERS) - Insider Monkey
Assenagon Asset Management S.A. Purchases 358,548 Shares of Cerus Corporation $CERS - Defense World
Financial Analysis: Cerus (NASDAQ:CERS) vs. PURE Bioscience (OTCMKTS:PURE) - Defense World
Cerus (CERS): Strong Growth Potential and Increased Valuation - GuruFocus
Why Cerus Corporation stock is recommended by analysts2025 Market Sentiment & Real-Time Volume Surge Alerts - Улправда
Can Cerus Corporation (CU2) stock test all time highs2025 Earnings Impact & AI Based Buy/Sell Signal Reports - Улправда
Can Cerus Corporation stock resist market sell offsJuly 2025 Market Mood & Weekly Consistent Profit Watchlists - Улправда
Cerus announces group purchasing pact with Blood Centers of America - MSN
Will Cerus Corporation stock beat EPS estimatesJuly 2025 Technicals & Short-Term Swing Trade Alerts - Улправда
Cerus Corporation (NASDAQ:CERS) Stock Catapults 33% Though Its Price And Business Still Lag The Industry - 富途牛牛
Cerus (NASDAQ:CERS) Share Price Crosses Above 200-Day Moving Average – What’s Next? - Defense World
Cerus (NASDAQ:CERS) Share Price Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat
Cerus Shares Surge on Strategic Deal and Financial Momentum - AD HOC NEWS
After-Hours Gainers: Biotech Stocks Climb On Data Anticipation And Momentum Buying - RTTNews
Cerus Corporation CU2 Stock Analysis and ForecastEvening Star Patterns & Exceptional Capital Trading - earlytimes.in
Cerus signs purchasing agreement with Blood Centers of America By Investing.com - Investing.com Nigeria
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America - Bakersfield.com
Cerus (NASDAQ:CERS) Stock Crosses Above 200 Day Moving Average – Should You Sell? - Defense World
Promising Penny Stocks To Watch In December 2025 - simplywall.st
Perhaps timely catching Cerus Corp (CERS) would be a good idea - setenews.com
Cerus (NASDAQ:CERS) Stock Crosses Above 200 Day Moving AverageShould You Sell? - MarketBeat
Why Cerus Corporation (CU2) stock stays resilientJuly 2025 Spike Watch & Real-Time Stock Entry Alerts - Newser
Published on: 2025-12-04 13:43:09 - Newser
How Cerus Corporation (CU2) stock trades pre earningsWeekly Trade Recap & Risk Controlled Swing Trade Alerts - Newser
Cerus Corporation (NASDAQ:CERS) Stock Catapults 31% Though Its Price And Business Still Lag The Industry - simplywall.st
Why Cerus Corporation (CU2) stock stays undervalued2025 Retail Activity & Daily Profit Focused Stock Screening - Newser
How Cerus Corporation (CU2) stock reacts to new regulationsAnalyst Downgrade & Consistent Return Strategy Ideas - Newser
Why analysts recommend Cerus Corporation (CU2) stockDollar Strength & Daily Profit Focused Screening - Newser
Why Cerus Corporation (CU2) stock is trending on social mediaQuarterly Market Summary & AI Powered Market Entry Strategies - Newser
Is Cerus Corporation (CU2) stock safe for risk averse investors2025 Risk Factors & Safe Capital Allocation Plans - Newser
Will Cerus Corporation (CU2) stock keep high P E multiplesPortfolio Performance Report & Entry Point Confirmation Signals - Newser
Can Cerus Corporation (CU2) stock sustain institutional flowsJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - Newser
Cerus (CERS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Cerus (NASDAQ:CERS) Shares Cross Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Cerus (NASDAQ:CERS) Shares Cross Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Don't Ignore The Insider Selling In Cerus - simplywall.st
Cerus Executive Offloads Thousands of Shares in Major Stock Sale - TipRanks
Insider Sell: Chrystal Jensen Sells 55,000 Shares of Cerus Corp (CERS) - GuruFocus
Cerus (CERS) Chief Legal Officer reports 55,000-share stock sale - Stock Titan
Officer Jensen Files To Sell 55,000 Of Cerus Corp [CERS] - TradingView
Cerus: IFC Growth And RBC Optionality (NASDAQ:CERS) - Seeking Alpha
Primecap Management Co. CA Has $1.86 Million Stock Holdings in Cerus Corporation $CERS - MarketBeat
What makes Cerus Corporation (CU2) stock appealing to growth investorsIndex Update & Fast Momentum Entry Tips - newser.com
Connor Clark & Lunn Investment Management Ltd. Acquires 97,592 Shares of Cerus Corporation $CERS - Defense World
Cerus to Release First Quarter 2013 Results on April 30, 2013 - AOL.com
Is Cerus Corporation stock resilient to inflation2025 Bull vs Bear & Momentum Based Trading Signals - newser.com
Cerus Corp Stock (CERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.07%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):